Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-04
DOI
10.1038/s41591-020-1005-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular surveillance of Pfcrt and k13 propeller polymorphisms of imported Plasmodium falciparum cases to Zhejiang Province, China between 2016 and 2018
- (2020) Xiaoxiao Wang et al. MALARIA JOURNAL
- A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites
- (2020) Jakob Birnbaum et al. SCIENCE
- Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania
- (2020) George M. Bwire et al. Scientific Reports
- Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance
- (2020) Luana C Mathieu et al. eLife
- Efficacy of artemether–lumefantrine versus dihydroartemisinin–piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial
- (2019) Aline Uwimana et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors
- (2019) Moses Ocan et al. MALARIA JOURNAL
- The contribution of functional antimalarial immunity to measures of parasite clearance in therapeutic efficacy studies of artemisinin derivatives
- (2019) Katherine O’Flaherty et al. JOURNAL OF INFECTIOUS DISEASES
- Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study
- (2019) William L Hamilton et al. LANCET INFECTIOUS DISEASES
- Antimalarial drug resistance in Africa: the calm before the storm?
- (2019) Melissa D Conrad et al. LANCET INFECTIOUS DISEASES
- Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
- (2019) Rob W van der Pluijm et al. LANCET INFECTIOUS DISEASES
- Protozoan persister-like cells and drug treatment failure
- (2019) Michael P. Barrett et al. NATURE REVIEWS MICROBIOLOGY
- Plasmodium falciparum resistance to piperaquine driven by PfCRT
- (2019) Satish K Dhingra et al. LANCET INFECTIOUS DISEASES
- Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study
- (2018) Roberto Amato et al. LANCET INFECTIOUS DISEASES
- Implications of population-level immunity for the emergence of artemisinin-resistant malaria: a mathematical model
- (2018) Nick Scott et al. MALARIA JOURNAL
- Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
- (2018) Leila S. Ross et al. Nature Communications
- The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study
- (2017) Mallika Imwong et al. LANCET INFECTIOUS DISEASES
- Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype–phenotype association study
- (2017) Roberto Amato et al. LANCET INFECTIOUS DISEASES
- A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study
- (2017) Benoit Witkowski et al. LANCET INFECTIOUS DISEASES
- Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic
- (2017) Benjamin Blasco et al. NATURE MEDICINE
- Antimalarial Drug Resistance: A Threat to Malaria Elimination
- (2017) Didier Menard et al. Cold Spring Harbor Perspectives in Medicine
- Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa
- (2016) Hannah C. Slater et al. MALARIA JOURNAL
- A Worldwide Map ofPlasmodium falciparumK13-Propeller Polymorphisms
- (2016) Didier Ménard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Surveillance of Artemisinin Resistance in Plasmodium falciparum in India Using the kelch13 Molecular Marker
- (2015) Neelima Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic architecture of artemisinin-resistant Plasmodium falciparum
- (2015) Olivo Miotto et al. NATURE GENETICS
- Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
- (2014) Elizabeth A. Ashley et al. NEW ENGLAND JOURNAL OF MEDICINE
- K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
- (2014) J. Straimer et al. SCIENCE
- Malaria
- (2013) Nicholas J White et al. LANCET
- Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies
- (2013) Benoit Witkowski et al. LANCET INFECTIOUS DISEASES
- Global malaria connectivity through air travel
- (2013) Zhuojie Huang et al. MALARIA JOURNAL
- A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
- (2013) Frédéric Ariey et al. NATURE
- Global malaria mortality between 1980 and 2010: a systematic analysis
- (2012) Christopher JL Murray et al. LANCET
- Artemisinin Resistance inPlasmodium falciparumMalaria
- (2009) Arjen M. Dondorp et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now